Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
ANI Pharmaceuticals, Inc. (ANIP) had Operating Cash Flow per Share of $5.46 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$211.37M |
|
$8.14M |
|
$74.61M |
|
$136.76M |
|
$197.48M |
|
$13.89M |
|
$-3.37M |
|
$10.53M |
|
$10.53M |
|
$8.55M |
|
$8.55M |
|
$8.55M |
|
$8.55M |
|
$13.89M |
|
$37.17M |
|
19.83M |
|
20.31M |
|
$0.37 |
|
$0.36 |
|
| Balance Sheet Financials | |
$602.63M |
|
$59.25M |
|
$740.37M |
|
$1.34B |
|
$236.84M |
|
$608.35M |
|
$644.56M |
|
$881.39M |
|
$436.76M |
|
$-119.25M |
|
$461.61M |
|
21.73M |
|
| Cash Flow Statement Financials | |
$110.80M |
|
$-26.75M |
|
$-11.65M |
|
$144.89M |
|
$217.83M |
|
$72.94M |
|
$18.47M |
|
-- |
|
$-0.81M |
|
| Fundamental Metrics & Ratios | |
2.54 |
|
-- |
|
-- |
|
0.57 |
|
1.35 |
|
64.70% |
|
6.57% |
|
6.57% |
|
-- |
|
4.98% |
|
3.85% |
|
$104.31M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.54 |
|
0.94 |
|
96.08 |
|
1.96% |
|
-7.17% |
|
0.64% |
|
0.80% |
|
$21.24 |
|
$5.14 |
|
|
Operating Cash Flow per Share |
$5.46 |